•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
For individuals researching home pulse oximeters for daily oxygen monitoring—whether for COPD management, post-surgery recovery, sleep-related concerns, or general wellness tracking—the Herz P1 Smart Oximeter is a product that continues to generate consumer interest. The device is marketed as a standalone fingertip pulse oxygen monitor with company-described accuracy specifications, smart alarm alerts, and a dual-color OLED display, with no app, Bluetooth, or subscription required.
This report summarizes how the Herz P1 Smart Oximeter is described in company-provided materials and related publicly available context. It also highlights what consumers should verify before relying on any home oximeter for health decisions.
Pulse oximeters estimate arterial blood oxygen saturation (SpO2) by passing light through the fingertip and measuring how much is absorbed by oxygenated versus deoxygenated hemoglobin. The displayed percentage is an approximation of how much oxygen blood is carrying. Normal SpO2 readings in healthy adults typically range from 95% to 100%, according to published clinical references.
Home pulse oximetry has been discussed in medical literature, including concerns about accuracy limitations. The FDA issued a safety communication in 2021 noting that pulse oximeters have limitations and that factors including skin pigmentation, poor circulation, skin thickness, skin temperature, tobacco use, and fingernail polish can affect reading accuracy. These limitations apply to the technology category, not only to one brand.
Herz P1 LLC positions the Herz P1 as a standalone fingertip pulse oximeter for daily home monitoring. The company’s marketing focuses on adults managing COPD, heart conditions, post-surgery recovery, and sleep-related oxygen concerns, as well as family members purchasing monitoring devices for elderly relatives.
The company describes a smart alarm system that triggers when SpO2 or pulse rate readings move outside a set range. The listed default alarm threshold for SpO2 is below 90%, with customizable thresholds based on a doctor’s recommendations.
The company describes a dual-color OLED display showing SpO2 in teal and pulse rate in amber, along with a live pulse waveform. The display is offered with six orientation modes for readability in different positions.
The company lists accuracy specifications of ±2% SpO2 accuracy in the clinical range and ±1 BPM pulse rate accuracy, describing these as clinical-range accuracy in its product materials.
The company describes the device as standalone, requiring no app, Bluetooth connection, charging cable, or subscription. Batteries are described as pre-installed (2x AAA alkaline), with auto power-off after 8 seconds to preserve battery life.
The device is listed at 30g (1.06 oz).
The Herz P1 product page features the phrase “FDA 510K Cleared.” In general, FDA 510(k) clearance is a regulatory pathway in which a manufacturer demonstrates that a device is substantially equivalent to a legally marketed predicate device. The report notes that 510(k) clearance is not the same as FDA approval and does not indicate that the FDA independently validated the device’s clinical performance through its own testing.
The report also notes that FDA registration is separate from clearance. Registration indicates a manufacturing facility has registered with the FDA, but it does not indicate that a specific product has been cleared or approved.
At the time of this report, a 510(k) clearance number for the Herz P1 Smart Oximeter was not identified in publicly accessible FDA database searches and should be verified directly with the manufacturer or through the FDA’s 510(k) Premarket Notification database.
The company lists ±2% SpO2 accuracy in the clinical range and ±1 BPM pulse rate accuracy. The report provides general context that published pulse oximetry standards (including ISO 80601-2-61) govern pulse oximeter performance testing, and FDA guidance for 510(k) pulse oximeter submissions references this standard and generally looks for an accuracy specification expressed as Arms (root mean square error) of approximately 3% or better for SpO2 in the 70–100% range.
The report emphasizes a distinction between listed specifications and validated performance. It states that confirming whether a device achieves its stated accuracy requires controlled hypoxia testing following ISO 80601-2-61 protocols, and that without access to published test data or a verified 510(k) summary, publicly available information alone may not confirm whether the stated accuracy has been validated through standard testing.
The company describes the alarm as triggering when SpO2 drops below 90% or when pulse rate moves outside a set range, with thresholds customizable based on a doctor’s recommendations. The report also notes that the product materials include customer feedback referencing overnight use and sleep-related discoveries.
However, the report highlights that the Herz P1 is described as a clip-on fingertip device with auto power-off after 8 seconds. For sleep-related monitoring, it advises clarifying with the company how the device functions during extended overnight use and discussing overnight oximetry options with a healthcare provider.
The Herz P1 Smart Oximeter is presented at a one-time price of $49.99. The company’s product page references percentage savings relative to a higher listed reference price. Shipping is described as fulfilled from a US warehouse with delivery in 2–3 business days. Pricing and terms are described as subject to change, and consumers are advised to verify current details on the official product page.
Orders are backed by a 90-day money-back guarantee. The report states that specific return shipping requirements, documentation needs, and processing timelines should be confirmed directly with the company before purchasing. Customer support email listed is support@herzp1.com.
The company’s Terms of Service describe automatic enrollment in a rewards program upon purchase. The report states that purchasing a Herz P1 product makes the buyer automatically eligible for “Herz P1 LLC Rewards,” described as providing shopping rewards in the form of cashback.
Activating these rewards requires linking a debit or credit card post-checkout within 30 days of purchase. The rewards program is described as powered by LIQUID Member Inc., with enrolled customers required to comply with LIQUID Rewards’ separate Terms of Service. The report advises reading the rewards program terms carefully before linking payment information.
The report states that the information is for informational purposes only and does not constitute medical, health, or professional advice. It also reiterates that pulse oximeters are screening tools that provide estimated measurements and do not replace professional medical evaluation, diagnosis, or treatment.
The report further notes that regulatory descriptions and accuracy specifications are attributed to the company’s published product page. It states that a 510(k) clearance number for this specific device was not identified in publicly accessible FDA database searches at the time of publication and should be verified directly with the manufacturer or through the FDA’s public database.
The report also includes an affiliate disclosure stating that the article contains affiliate links and that a commission may be earned at no additional cost to the buyer if a purchase is made through those links.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
